12/20
06:53 am
eton
Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection) [Yahoo! Finance]
Medium
Report
Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection) [Yahoo! Finance]
12/20
06:50 am
eton
Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)
Medium
Report
Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)
12/17
07:32 am
eton
Eton Pharmaceuticals Announces Final Readout of PKU GOLIKE® Clinical Trial [Yahoo! Finance]
Medium
Report
Eton Pharmaceuticals Announces Final Readout of PKU GOLIKE® Clinical Trial [Yahoo! Finance]
12/17
06:50 am
eton
Eton Pharmaceuticals Announces Final Readout of PKU GOLIKE® Clinical Trial
Low
Report
Eton Pharmaceuticals Announces Final Readout of PKU GOLIKE® Clinical Trial
12/12
11:36 am
eton
Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) top owners are retail investors with 58% stake, while 26% is held by institutions [Yahoo! Finance]
Low
Report
Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) top owners are retail investors with 58% stake, while 26% is held by institutions [Yahoo! Finance]
12/3
06:50 am
eton
Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial Officer
Medium
Report
Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial Officer
11/26
08:00 am
eton
Eton Pharmaceuticals, Inc. (NASDAQ: ETON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock, up previously from $11.00.
Medium
Report
Eton Pharmaceuticals, Inc. (NASDAQ: ETON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock, up previously from $11.00.
11/25
06:58 am
eton
Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension) [Yahoo! Finance]
Low
Report
Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension) [Yahoo! Finance]
11/25
06:50 am
eton
Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension)
Medium
Report
Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension)
11/18
10:40 am
eton
What Makes Eton Pharmaceuticals (ETON) a Good Fit for 'Trend Investing' [Yahoo! Finance]
Low
Report
What Makes Eton Pharmaceuticals (ETON) a Good Fit for 'Trend Investing' [Yahoo! Finance]
11/15
08:16 am
eton
Eton Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
Medium
Report
Eton Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
11/13
09:10 am
eton
Eton Pharmaceuticals, Inc. (NASDAQ: ETON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.
High
Report
Eton Pharmaceuticals, Inc. (NASDAQ: ETON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.
11/13
02:26 am
eton
Eton Pharmaceuticals Inc (ETON) Q3 2024 Earnings Call Highlights: Record Sales and Strategic ... [Yahoo! Finance]
High
Report
Eton Pharmaceuticals Inc (ETON) Q3 2024 Earnings Call Highlights: Record Sales and Strategic ... [Yahoo! Finance]
11/12
04:12 pm
eton
Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results [Yahoo! Finance]
High
Report
Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results [Yahoo! Finance]
11/12
04:01 pm
eton
Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results
High
Report
Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results
11/11
07:33 am
eton
What To Expect From Eton Pharmaceuticals Inc (ETON) Q3 2024 Earnings [Yahoo! Finance]
Medium
Report
What To Expect From Eton Pharmaceuticals Inc (ETON) Q3 2024 Earnings [Yahoo! Finance]
11/7
07:00 am
eton
Eton Pharmaceuticals Awarded Second Patent for ET-400 (Hydrocortisone Oral Solution)
Low
Report
Eton Pharmaceuticals Awarded Second Patent for ET-400 (Hydrocortisone Oral Solution)
11/6
04:30 pm
eton
Eton Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
Low
Report
Eton Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
10/28
11:05 am
eton
Eton Pharmaceuticals, Inc. (NASDAQ: ETON) had its price target raised by analysts at Craig Hallum from $10.00 to $15.00. They now have a "buy" rating on the stock.
Low
Report
Eton Pharmaceuticals, Inc. (NASDAQ: ETON) had its price target raised by analysts at Craig Hallum from $10.00 to $15.00. They now have a "buy" rating on the stock.
10/23
01:08 am
eton
Ipsen delivers strong sales momentum in the first nine months of 2024 and increases its full-year guidance [Financial Post (Toronto, Ontario, Canada)]
Low
Report
Ipsen delivers strong sales momentum in the first nine months of 2024 and increases its full-year guidance [Financial Post (Toronto, Ontario, Canada)]
10/14
08:46 am
eton
Analysts Expect Breakeven For Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Before Long [Yahoo! Finance]
Low
Report
Analysts Expect Breakeven For Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Before Long [Yahoo! Finance]
10/4
09:54 am
eton
Eton Pharmaceuticals, Inc. (NASDAQ: ETON) had its price target raised by analysts at Craig Hallum from $8.00 to $10.00. They now have a "buy" rating on the stock.
Medium
Report
Eton Pharmaceuticals, Inc. (NASDAQ: ETON) had its price target raised by analysts at Craig Hallum from $8.00 to $10.00. They now have a "buy" rating on the stock.
10/4
08:06 am
eton
Eton Pharmaceuticals, Inc. (NASDAQ: ETON) had its price target raised by analysts at HC Wainwright from $9.00 to $11.00. They now have a "buy" rating on the stock.
Low
Report
Eton Pharmaceuticals, Inc. (NASDAQ: ETON) had its price target raised by analysts at HC Wainwright from $9.00 to $11.00. They now have a "buy" rating on the stock.
10/3
06:44 am
eton
Eton Pharmaceuticals, Inc to Acquire Increlex® (mecasermin injection) from Ipsen [Yahoo! Finance]
High
Report
Eton Pharmaceuticals, Inc to Acquire Increlex® (mecasermin injection) from Ipsen [Yahoo! Finance]
10/3
06:42 am
eton
Eton Pharmaceuticals to buy Increlex product from Ipsen [Seeking Alpha]
High
Report
Eton Pharmaceuticals to buy Increlex product from Ipsen [Seeking Alpha]